Target of alternative antimicrobial approach: bacterial pathogenesis regulated by cyclic di-GMP signaling system
Project/Area Number |
23790925
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Respiratory organ internal medicine
|
Research Institution | Toho University |
Principal Investigator |
|
Project Period (FY) |
2011-04-28 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2013: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2011: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
Keywords | 感染症 / 緑膿菌 / 肺炎 / マウス / Quorum sensing / cyclic di-GMP / c-di-GMP / バイオフィルム / 病原性 |
Outline of Final Research Achievements |
Macrolides have been reported to exert a variety of effects on both host immunomodulation as well as repression of bacterial pathogenicity. In this study, we report that the 3′,5′-cyclic diguanylic acid (c-di-GMP) signaling system, which regulates virulence to the host, was affected by the macrolide azithromycin (AZM). Using DNA microarray analysis, we selected two Pseudomonas aeruginosa genes related to c-di-GMP metabolism that were significantly affected by AZM treatment. The expression of these genes was significantly repressed by AZM in a time- and dose-dependent manner, whereas no difference in pde gene expression was observed in the absence of AZM. In-frame deletion of the pde gene affected both virulence factors and the quorum-sensing system and significantly decreased total bacteria in a mouse pneumonia model compared to the wild-type strain. These results suggest that macrolides affect virulence factor production via the c-di-GMP regulatory system.
|
Report
(5 results)
Research Products
(10 results)